A collaborative approach to greater diversity in clinical trialsThe need for diversity in clinical trial populations has been a topic of discussion across regulators and the Share XA collaborative approach to greater diversity in clinical trialshttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/a-collaborative-approach-to-greater-diversity-in-clinical-trials/
FDA panel backs Sage’s novel antidepressant but turns down Alkermes’Sage’s Zulresso (brexanolone) is on course for approval for postnatal depression in the US after a positive vote Share XFDA panel backs Sage’s novel antidepressant but turns down Alkermes’https://pharmaphorum.com/news/fda-panel-backs-sages-novel-antidepressant-but-turns-down-alkermes/